Healthcare
Live Price
Offline$0.339
-3.14% today
1Y Change
+52.17%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
QHSLab, Inc. (USAQ) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.34 and up 52.2% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +26.3%, EPS growth of +258.7%, a dividend yield of 0.0%. What stands out right now is revenue +26.3%, EPS +258.7%, free cash flow +25.1% with operating margin 4.9% and ROIC 7.5%. Valuation is more restrained than many high-expectation growth names at P/E 15.3 and price/sales 2.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines USAQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
USAQ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
USAQ Max Drawdown
-72.82%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for USAQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.4M
+13.8% YoY
FY Net Income
-$770.2K
+22.7% YoY
Free Cash Flow
-$509.3K
-31.2% YoY
Revenue Growth
+26.3%
EPS Growth
+258.7%
Gross Margin
67.3%
Net Margin
17.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 3M | 2M | 1M | 1M | 1M |
| Gross Profit | 2M | 1M | 794K | 620K | 671K |
| Operating Income | 131K | 206K | -240K | -561K | -502K |
| EBITDA | 786K | 352K | -91K | -435K | -488K |
| Net Income | 457K | -259K | -468K | -996K | -770K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 636K | 157K | 52K | 179K | 287K |
| Total Assets | 2M | 2M | 2M | 2M | 2M |
| Total Liabilities | 546K | 2M | 2M | 2M | 1M |
| Shareholder Equity | 2M | -608K | -376K | 76K | 824K |
| Total Debt | 20K | 2M | 2M | 2M | 1M |
| Net Debt | -616K | 2M | 2M | 1M | 1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
355K
-1.1% YoY
Capital Expenditures
155K
-316.4% YoY
Free Cash Flow
509K
-31.2% YoY
Key ratios
Gross Margin
67.3%
Operating Margin
4.9%
Net Margin
17.0%
ROE
-825.4%
Debt / Equity
0.01x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.